Trial Information
Inclusion Criteria:
- The clinical diagnosis criteria for PCOS by European Society of Human Reproduction
and Embryology, and Rotterdam working group of American Society for Reproductive
Medicine (ESHRE /ASRM )
Exclusion Criteria:
- hyperprolactinemia and other endocrine diseases such as high androgen hormone in
blood, namely Cushing's syndrome, congenital adrenal hyperplasia ( CAH ), ovarian or
adrenal tumor and so on
Type of Study:
Observational
Study Design:
Observational Model: Case Control
Outcome Measure:
The potentially biochemical diagnosis criteria and therapeutic effect evaluation indexes: Sex hormone binding globulin levels and free androgen index in blood of patients with polycystic ovary syndrome
Outcome Time Frame:
after 5 weeks of ovulation treatment
Safety Issue:
Yes
Authority:
United States: Food and Drug Administration
Study ID:
2006A165
NCT ID:
NCT01784380
Start Date:
October 2006
Completion Date:
October 2012
Related Keywords:
- The Investigators Collected 534 PCOS Patients as the Case Group,and 580 Infertile Women With Normal Ovulatory Cycle of the Control Group;
- At the Same Time, the Investigators Continuedly Collect Cases to October 2012, and Totally Collected 579 Patients With PCOS Altogether;
- 534 Patients in the Cases Group and 580 Women in the Control Group Received no Measures, While 579 Patients Received Drugs;
- The Investigators Monitored Basic Indexes in Blood of All the Subjects in This Suvey,and Also Monitored Indexes of 579 Patients After Treatment.
- Polycystic Ovary Syndrome